Mechanisms of Mas1 Receptor-Mediated Signaling in the Vascular Endothelium

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 37, Issue 3, 2017, Pages 433-445

  Hoffmann, Brian R ^a   Stodola, Timothy J ^a   Wagner, Jordan R ^a   Didier, Daniela N ^a   Exner, Eric C ^a   Lombard, Julian H ^a   Greene, Andrew S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

angiotensin II; endothelium, vascular; phenotype; renin Angiotensin system; vasodilation

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; MAS1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE D; PROTEIN KINASE D1; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN I (1-7); ANGIOTENSIN II; G PROTEIN COUPLED RECEPTOR; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION; AGONISTS; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; ELECTROSTIMULATION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; INNERVATION; MALE; METABOLISM; MIDDLE CEREBRAL ARTERY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; MALE; MIDDLE CEREBRAL ARTERY; NEOVASCULARIZATION, PHYSIOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; VASODILATION;

EID: 85010845201     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307787     Document Type: Article

References (48)

1. Moon JY, Recent update of renin-Angiotensin-Aldosterone system in the pathogenesis of hypertension. Electrolyte Blood Press 2013 11 41 45. doi: 10.5049/EBP.2013.11.2.41.
2. Balakumar P, Jagadeesh G, A century old renin-Angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology. Cell Signal 2014 26 2147 2160. doi: 10.1016/j.cellsig.2014.06.011.
3. Xu P, Sriramula S, Lazartigues E, ACE2/ANG-(1-7)/Mas pathway in the brain: The axis of good. Am J Physiol Regul Integr Comp Physiol 2011 300 R804 R817. doi: 10.1152/ajpregu.00222.2010.
4. Wang W, Bodiga S, Das SK, Lo J, Patel V, Oudit GY, Role of ACE2 in diastolic and systolic heart failure. Heart Fail Rev 2012 17 683 691. doi: 10.1007/s10741-011-9259-x.
5. Kamo T, Akazawa H, Komuro I, Pleiotropic effects of angiotensin II receptor signaling in cardiovascular homeostasis and aging. Int Heart J 2015 56 249 254. doi: 10.1536/ihj.14-429.
6. Durand MJ, Raffai G, Weinberg BD, Lombard JH, Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries. Am J Physiol Heart Circ Physiol 2010 299 H1024 H1033. doi: 10.1152/ajpheart.00328.2010.
7. Petersen MC, Munzenmaier DH, Greene AS, Angiotensin II infusion restores stimulated angiogenesis in the skeletal muscle of rats on a high-salt diet. Am J Physiol Heart Circ Physiol 2006 291 H114 H120. doi: 10.1152/ajpheart.01116.2005.
8. Santos RA, Simoes e Silva AC, Maric C, Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 2003 100 8258 8263. doi: 10.1073/pnas.1432869100.
9. Benter IF, Yousif MH, Anim JT, Cojocel C, Diz DI, Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Am J Physiol Heart Circ Physiol 2006 290 H684 H691. doi: 10.1152/ajpheart.00632.2005.
10. Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM, Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007 49 185 192. doi: 10.1161/01.HYP.0000251865.35728.2f.
11. Wang Y, Qian C, Roks AJ, Westermann D, Schumacher SM, Escher F, Schoemaker RG, Reudelhuber TL, van Gilst WH, Schultheiss HP, Tschöpe C, Walther T, Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction. Circ Heart Fail 2010 3 286 293. doi: 10.1161/CIRCHEARTFAILURE.109.905968.
12. Raffai G, Durand MJ, Lombard JH, Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats. Am J Physiol Heart Circ Physiol 2011 301 H1341 H1352. doi: 10.1152/ajpheart.00202.2011.
13. Xue H, Zhou L, Yuan P, Wang Z, Ni J, Yao T, Wang J, Huang Y, Yu C, Lu L, Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells. Regul Pept 2012 177 12 20. doi: 10.1016/j.regpep.2012.04.002.
14. Souza ÁP, Sobrinho DB, Almeida JF, Alves GM, Macedo LM, Porto JE, Vêncio EF, Colugnati DB, Santos RA, Ferreira AJ, Mendes EP, Castro CH, Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts. Clin Sci (Lond) 2013 125 449 459. doi: 10.1042/CS20120519.
15. Loot AE, Roks AJ, Henning RH, Tio RA, Suurmeijer AJ, Boomsma F, van Gilst WH, Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002 105 1548 1550
16. Guimaraes PS, Santiago NM, Xavier CH, Velloso EP, Fontes MA, Santos RA, Campagnole-Santos MJ, Chronic infusion of angiotensin-(1-7) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats. Am J Physiol Heart Circ Physiol 2012 303 H393 H400. doi: 10.1152/ajpheart.00075.2012.
17. Fraga-Silva RA, Da Silva DG, Montecucco F, Mach F, Stergiopulos N, da Silva RF, Santos RA, The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: A potential target for treating thrombotic diseases. Thromb Haemost 2012 108 1089 1096. doi: 10.1160/TH12-06-0396.
18. Liu GC, Oudit GY, Fang F, Zhou J, Scholey JW, Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells. Am J Physiol Renal Physiol 2012 302 F784 F790. doi: 10.1152/ajprenal.00455.2011.
19. Verano-Braga T, Schwämmle V, Sylvester M, Passos-Silva DG, Peluso AA, Etelvino GM, Santos RA, Roepstorff P, Time-resolved quantitative phosphoproteomics: new insights into Angiotensin-(1-7) signaling networks in human endothelial cells. J Proteome Res 2012 11 3370 3381. doi: 10.1021/pr3001755.
20. Meinert C, Gembardt F, Böhme I, Tetzner A, Wieland T, Greenberg B, Walther T, Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7). J Proteomics 2016 130 129 139. doi: 10.1016/j.jprot.2015.09.020.
21. Karcher JR, Greene AS, Bone marrow mononuclear cell angiogenic competency is suppressed by a high-salt diet. Am J Physiol Cell Physiol 2014 306 C123 C131. doi: 10.1152/ajpcell.00164.2013.
22. Hoffman MJ, Flister MJ, Nunez L, Xiao B, Greene AS, Jacob HJ, Moreno C, Female-specific hypertension loci on rat chromosome 13. Hypertension 2013 62 557 563. doi: 10.1161/HYPERTENSIONAHA.113.01708.
23. Freed JK, Greene AS, Proteomic analysis of shear stress-mediated protection from TNF-Alpha in endothelial cells. Microcirculation 2010 17 259 270. doi: 10.1111/j.1549-8719.2010.00031.x.
24. Moreno C, Kaldunski ML, Wang T, Roman RJ, Greene AS, Lazar J, Jacob HJ, Cowley AW Jr., Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genomics 2007 31 228 235. doi: 10.1152/physiolgenomics.00280.2006.
25. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA, The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003 42 1149 1160
26. Hoffmann BR, Wagner JR, Prisco AR, Janiak A, Greene AS, Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress. Physiol Genomics 2013 45 1021 1034. doi: 10.1152/physiolgenomics.00070.2013.
27. McEwen ST, Schmidt JR, Somberg L, Cruz Lde L, Lombard JH, Time-course and mechanisms of restored vascular relaxation by reduced salt intake and angiotensin II infusion in rats fed a high-salt diet. Microcirculation 2009 16 220 234. doi: 10.1080/10739680802544177.
28. McEwen ST, Balus SF, Durand MJ, Lombard JH, Angiotensin II maintains cerebral vascular relaxation via EGF receptor transactivation and ERK1/2. Am J Physiol Heart Circ Physiol 2009 297 H1296 H1303. doi: 10.1152/ajpheart.01325.2008.
29. Ghiadoni L, Versari D, Magagna A, Kardasz I, Plantinga Y, Giannarelli C, Taddei S, Salvetti A, Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens 2007 25 361 366. doi: 10.1097/HJH.0b013e3280115901.
30. Hitomi H, Kiyomoto H, Nishiyama A, Angiotensin II and oxidative stress. Curr Opin Cardiol 2007 22 311 315. doi: 10.1097/HCO.0b013e3281532b53.
31. Ogawa S, Mori T, Nako K, Kato T, Takeuchi K, Ito S, Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy. Hypertension 2006 47 699 705. doi: 10.1161/01.HYP.0000203826.15076.4b.
32. Touyz RM, Schiffrin EL, Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 2001 19 1245 1254
33. Zhu J, Drenjancevic-Peric I, McEwen S, Friesema J, Schulta D, Yu M, Roman RJ, Lombard JH, Role of superoxide and angiotensin II suppression in salt-induced changes in endothelial Ca2+ signaling and NO production in rat aorta. Am J Physiol Heart Circ Physiol 2006 291 H929 H938. doi: 10.1152/ajpheart.00692.2005.
34. de Resende MM, Amaral SL, Moreno C, Greene AS, Congenic strains reveal the effect of the renin gene on skeletal muscle angiogenesis induced by electrical stimulation. Physiol Genomics 2008 33 33 40. doi: 10.1152/physiolgenomics.00150.2007.
35. Kaczorowski CC, Stodola TJ, Hoffmann BR, Prisco AR, Liu PY, Didier DN, Karcher JR, Liang M, Jacob HJ, Greene AS, Targeting the endothelial progenitor cell surface proteome to identify novel mechanisms that mediate angiogenic efficacy in a rodent model of vascular disease. Physiol Genomics 2013 45 999 1011. doi: 10.1152/physiolgenomics.00097.2013.
36. Stodola TJ, de Resende MM, Sarkis AB, Didier DN, Jacob HJ, Huebner N, Hummel O, Saar K, Moreno C, Greene AS, Characterization of the genomic structure and function of regions influencing renin and angiogenesis in the SS rat. Physiol Genomics 2011 43 808 817. doi: 10.1152/physiolgenomics.00171.2010.
37. de Resende MM, Greene AS, Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation. Am J Physiol Heart Circ Physiol 2008 294 H2814 H2821. doi: 10.1152/ajpheart.00095.2008.
38. Amaral SL, Linderman JR, Morse MM, Greene AS, Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation 2001 8 57 67
39. Linderman JR, Kloehn MR, Greene AS, Development of an implantable muscle stimulator: measurement of stimulated angiogenesis and poststimulus vessel regression. Microcirculation 2000 7 119 128
40. Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA, Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol Cancer Ther 2009 8 1676 1683. doi: 10.1158/1535-7163.MCT-09-0161.
41. Singh N, Vasam G, Pawar R, Jarajapu YP, Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes. J Sex Med 2014 11 2153 2163. doi: 10.1111/jsm.12620.
42. Tamarat R, Silvestre JS, Durie M, Levy BI, Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor-and inflammation-related pathways. Lab Invest 2002 82 747 756
43. James PA, Oparil S, Carter BL, 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014 311 507 520. doi: 10.1001/jama.2013.284427.
44. Nie W, Yan H, Li S, Zhang Y, Yu F, Zhu W, Fan F, Zhu J, Angiotensin-(1-7) enhances angiotensin II induced phosphorylation of ERK1/2 in mouse bone marrow-derived dendritic cells. Mol Immunol 2009 46 355 361. doi: 10.1016/j.molimm.2008.10.022.
45. Von Bohlen und Halbach O, Walther T, Bader M, Albrecht D, Interaction between Mas and the angiotensin AT1 receptor in the amygdala. J Neurophysiol 2000 83 2012 2021
46. Castro CH, Santos RA, Ferreira AJ, Bader M, Alenina N, Almeida AP, Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart. Hypertension 2005 46 937 942. doi: 10.1161/01.HYP.0000175813.04375.8a.
47. Zimpelmann J, Burns KD, Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells. Am J Physiol Renal Physiol 2009 296 F337 F346. doi: 10.1152/ajprenal.90437.2008.
48. Zhou LM, Shi Z, Gao J, Han Y, Yuan N, Gao XY, Zhu GQ, Angiotensin-(1-7) and angiotension II in the rostral ventrolateral medulla modulate the cardiac sympathetic afferent reflex and sympathetic activity in rats. Pflugers Arch 2010 459 681 688. doi: 10.1007/s00424-010-0793-5.